RxDoctor Payments Data

Michael Steigner, MD

Diagnostic Radiology · Boston, MANPI 1538373840

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $495,210 of the $503,592 with a category attached, or 98.3%. Pfizer accounts for 93.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $170,975 and has fallen 99.9% since, to $120 in 2025. Among diagnostic radiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$503,592in general payments, 2019–2025

Across 136 payments — averaging $3702.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$468K
  • Seagen Inc.$15K
  • Merck$12K
  • Canon Medical Informatics, Inc.$8K
$82,460in research payments, 2019–2025

Across 19 payments — averaging $4340.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$50K
  • Hoffmann-la Roche Limited$31K
  • Janssen Research & Development, LLC$2K
  • AbbVie$80

What the payments were for

  • Consulting fees$495,21098%
  • Speaking & faculty fees$7,8282%
  • Travel & lodging$4880%
  • Food & beverage$660%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer98$468,465
Seagen Inc.9$14,880
Merck22$11,865
Canon Medical Informatics, Inc.7$8,382

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$503,592 in reported general payments places this provider in the 95th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$151,054
Medicare patients
1,150
Services billed
1,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →